Broker change
Cavendish Capital Markets appointed Nominated Adviser and Joint Broker; Peel Hunt LLP appointed Joint Broker.
Select text to share a quote on X · sign in to keep highlights & notes in your HVO notes
hVIVO plc (AIM & Euronext: HVO), the world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces the appointment of Cavendish Capital Markets Limited as Nominated Adviser and Joint Broker and Peel Hunt LLP as Joint Broker with immediate effect.
Existing Board - AIM Rule 17 Disclosure
The Company announces the following additional director disclosures pursuant to AIM Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies.
Elaine Sullivan
In addition to the disclosures made in Elaine Sullivan's announcement of appointment on 24 November 2020, the following directorships are disclosed:
| Company | Current, or last 5 years |
| Carrick Therapeutics Limited | Directorship held in last 5 years, at time of appointment to hVIVO |
Brendan Buckley
The following directorships were disclosed incorrectly in the Company's Admission Document dated 9 December 2019:
| Company | Disclosure |
| Irish Platform for Patients' Organisations, Science and Industry Company Limited | Directorship held more than 5 years prior to publication of the Admission Document and therefore should not have been disclosed in the Admission Document |
Cathal Friel
In addition to the disclosures made in the Admission Document dated 9 December 2019, the following directorships are disclosed:
| Company | Current, or last 5 years |
| Amryt Pharma Holdings Limited | Directorship held in last 5 years at time of Admission Document publication |
| Venn Life Sciences Limited Venn Life Sciences (Germany) GmbH Venn Life Sciences (Ireland) Limited Venn Life Sciences (NI) Limited Venn Life Sciences (Australia) Pty Ltd Venn Life Sciences Inc. Venn Life Sciences Legal Representation B.V Venn Life Sciences ED B.V. Venn Life Sciences (France) SAS Venn Life Sciences B.V. | Current directorship at the time of Admission Document publication |
The following directorships were disclosed incorrectly in the Company's Admission Document dated 9 December 2019:
| Company | Current, or last 5 years |
| Amryt Pharma plc | Incorrectly disclosed as a directorship |
| Fastnet Hydrocarbons Limited Raglan Natural Resources Limited | Directorship held in last 5 years at time of Admission Document publication. These directorships were disclosed as current directorships in the Admission Document |
| Fitzwilliam Place Capital Limited | Directorship held more than 5 years prior to Admission Document publication and therefore should not have been disclosed in the Admission Document |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.